How is tranexamic acid for melasma different in pregnancy?

Tranexamic acid may be used for melasma in topical or oral forms, but these routes are not interchangeable. Pregnancy itself changes the background risk of blood clots, so an oral medicine that affects clot breakdown should not be started, restarted or shared without the prescribing clinician and maternity team considering the full history. Melasma can also deepen with hormonal changes and sunlight during pregnancy, which means colour may fluctuate even when a treatment is working.

Tell your dermatologist and obstetric clinician that you are pregnant, trying to conceive or breastfeeding before using tranexamic acid. Bring the product name, route and strength, plus your history of clots, clotting disorders, migraine with aura, smoking, immobility and medicines containing oestrogen. Use gentle skin care and consistent broad-spectrum sun protection approved for pregnancy; avoid adding strong lightening products or procedures without advice. A clinician can choose whether to pause treatment, use a different approach or monitor the pigmentation.

Contact the prescribing team promptly if you develop new leg swelling or pain, sudden chest pain, unexplained breathlessness, coughing blood, a severe unusual headache or sudden vision changes while taking any prescribed medicine. These symptoms need urgent medical assessment. For melasma alone, seek review if a patch changes rapidly, bleeds, crusts or looks unlike the surrounding pigmentation.

Ask which route, if any, is appropriate in your pregnancy, whether your personal clot history changes the plan, and what alternatives can control melasma. Clarify when treatment can be reconsidered after delivery, whether breastfeeding affects the choice, and how to manage pigment safely in the meantime.